{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:56:37Z","timestamp":1785606997660,"version":"3.56.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Palacky University Olomouc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinsonian disorders comprise a broad spectrum of neurodegenerative diseases with a wide variety of pathogenetic processes. These processes lead to the formation of pathological proteins, resulting in the brain diseases called synucleinopathies, tauopathies or TDP-43 proteinopathies. There is currently growing support for the hypothesis that genetic variants explain a significant fraction of the etiology of apparently sporadic parkinsonian disorders. Genetic risk factors can be stratified according to the metabolic or structural processes that can lead to cellular disturbance;\u00a0these processes involve protein aggregation, protein and membrane trafficking, stabilization of the neurite structure, prion-like transmission of pathological proteins, ubiquitin\u2013proteasome system balance, mitophagy, lysosome autophagy, synaptic functions, and dopamine transmission. Regarding the environmental risk factors, there are several substances that have been supposed of being a risk for the development of neurodegenerative proteinopathy and Parkinsonism, mainly the agents used in agriculture and the textile industry. The most important and most frequently studied are pesticides and trichlorethylene. Beside the globally ubiquitous substances which are supposedly neurotoxic and exposure to which can cause manifestations of Parkinsonism, there are more geographically (regionally) specific substances, which cause (or quite recently caused) the manifestation of endemically present Parkinsonism. Among ten types of endemic Parkinsonism, three of them are thought to have an environmental cause: Western Pacific Parkinsonism, Caribbean Parkinsonism, and North France cluster of atypical Parkinsonism.<\/jats:p>","DOI":"10.1007\/s00702-025-03058-z","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:56:14Z","timestamp":1775490974000},"page":"1105-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic and environmental risk factors of Parkinsonism"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9009-3241","authenticated-orcid":false,"given":"Petr","family":"Kanovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-3160","authenticated-orcid":false,"given":"Katerina","family":"Mensikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3848-7091","authenticated-orcid":false,"given":"Pavel","family":"Cupr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7546-5676","authenticated-orcid":false,"given":"Radek","family":"Vodicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Kolarikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5784-0816","authenticated-orcid":false,"given":"Tereza","family":"Strnadova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-947X","authenticated-orcid":false,"given":"Sarah Elizabeth Victoria","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4446-0060","authenticated-orcid":false,"given":"Dorota","family":"Sebelova-Konickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-5307","authenticated-orcid":false,"given":"Jana","family":"Klanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2216-3973","authenticated-orcid":false,"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-1389","authenticated-orcid":false,"given":"Raymond","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"3058_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105855","volume":"116","author":"A Abusrair","year":"2023","unstructured":"Abusrair A, Mititelu A, Pfeffer G, Rosenegger L, Aquino CC (2023) Novel RAB39B variant associated intellectual disability and levodopa-responsive young-onset Parkinsonism. Park Relat Disord 116:105855","journal-title":"Park Relat Disord"},{"key":"3058_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/toxsci\/kfad090","volume":"196","author":"A Adamson","year":"2023","unstructured":"Adamson A, Ilieva N, Stone WJ, De Miranda BR (2023) Low-dose inhalation exposure to trichlorethylene induces dopaminergic neurodegeneration in rodents. Toxicol Sci 196:218\u2013228","journal-title":"Toxicol Sci"},{"key":"3058_CR3","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987","journal-title":"Front Aging Neurosci"},{"key":"3058_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu I, Bennet AL (2019) Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u00b4 s disease. Front Neurosci 13:328","journal-title":"Front Neurosci"},{"key":"3058_CR5","doi-asserted-by":"publisher","first-page":"1248828","DOI":"10.3389\/fneur.2023.1248828","volume":"14","author":"P Alizadeh","year":"2023","unstructured":"Alizadeh P, Terroba-Chambi C, Achen B, Bruno V (2023) Pain in monogenic Parkinson\u2019s disease: a comprehensive review. Front Neurol 14:1248828","journal-title":"Front Neurol"},{"key":"3058_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41598-019-56930-w","volume":"10","author":"C Alquezar","year":"2020","unstructured":"Alquezar C, Felix JB, McCandlish E, Buckley BT, Caparros-Lefebvre D, Karch CM, Golbe LI, Kao AW (2020) Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death incultured neurons. Sci Rep 10:569","journal-title":"Sci Rep"},{"key":"3058_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-020-00954-1","volume":"8","author":"K Ando","year":"2020","unstructured":"Ando K, Ndjim M, Turbant S, Fontaine G, Pregoni G, Dauphinot L, Yilmaz Z, Suain V, Mansour S, Authelet M, De Dekker R, Leroy K, Delatour B, Network BBNN, Duyckaerts C, Potier MC, Brion JP (2020) The lipid phosphatase synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brains lesions in Alzheimer\u00b4s disease. Acta Neuropathol Comm 8:79","journal-title":"Acta Neuropathol Comm"},{"key":"3058_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12015-022-10489-8","volume":"19","author":"AF Assoni","year":"2023","unstructured":"Assoni AF, Foijer F, Zatz M (2023) Amyotrophic lateral sclerosis, FUS and protein synthesis defects. Stem Cell Rev Rep 19:625\u2013638","journal-title":"Stem Cell Rev Rep"},{"key":"3058_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2019.00218","volume":"10","author":"N Ball","year":"2019","unstructured":"Ball N, Teo WP, Chandra S, Chapman J (2019) Parkinson\u00b4s disease and environment. Front Neurol 10:218","journal-title":"Front Neurol"},{"key":"3058_CR10","first-page":"112","volume":"7","author":"NH Baradd","year":"2024","unstructured":"Baradd NH, Sankhla C (2024) SCA15 presenting with Parkinsonism-dystonia, tremor and psychosis in an Indian woman. Ann Mov Disord 7:112\u2013115","journal-title":"Ann Mov Disord"},{"key":"3058_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/mds.27895","volume":"35","author":"G Bellomo","year":"2020","unstructured":"Bellomo G, Paciotti S, Gatticchi L, Parnetti L (2020) The vicious cycle between \u03b1-synuclein aggregation and autophagic-lysosomal dysfunction. Mov Disord 35:34\u201344","journal-title":"Mov Disord"},{"key":"3058_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083034","volume":"389","author":"B Blass","year":"2025","unstructured":"Blass B, Ford CB, Soneji S, Zepel L, Rosa TD, Kaufman BG, Mantri S, Li F, Mac Grory B, Xian Y, Johnson KG, O\u2019Brien R, Hammill BG, O\u2019Brien EC, Lusk JB (2025) Incidence and prevalence of dementia among US Medicare beneficiaries, 2015\u201321: population-based study. BMJ 389:e083034","journal-title":"BMJ"},{"key":"3058_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3233\/JPD-230250","volume":"13","author":"JS Bogers","year":"2023","unstructured":"Bogers JS, Bloem BR, Den Heijer JM (2023) The etiology of Parkinson\u2019s disease: new perspectives from gene-environment interactions. J Parkinsons Dis 13:1281\u20131288","journal-title":"J Parkinsons Dis"},{"key":"3058_CR170","doi-asserted-by":"crossref","unstructured":"Breydo L, Wu JW, Uversky VN. \u03b1-synuclein misfolding in Parkinson\u00b4s disease. Bioch Biophys Acta 2012; 1822: 261 - 285","DOI":"10.1016\/j.bbadis.2011.10.002"},{"key":"3058_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/mds.30067","volume":"40","author":"KA Brolin","year":"2025","unstructured":"Brolin KA, Schaeffer E, Kuri A, Rumrich IK, Schuh SAF, Darweesh SKL, Kaasinen V, Tolppanen AM, Chahine LM, Noyce AJ (2024) Environmental risk factors for Parkinson\u00b4s disease: a critical review and policy implications. Mov Disord 40:204\u2013221","journal-title":"Mov Disord"},{"key":"3058_CR15","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1002\/alz.13784","volume":"20","author":"S Buchholz","year":"2024","unstructured":"Buchholz S, Zempel H (2024) The six brain-specific tau isoforms and their role in Alzheimer\u00b4s disease and relared neurodegenerative dementia syndromes. Alzheimers Dement 20:3606\u20133628","journal-title":"Alzheimers Dement"},{"key":"3058_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neulet.2017.11.057","volume":"665","author":"M Cai","year":"2018","unstructured":"Cai M, Liu Z, Li W, Wang Y, Xie A (2018) Association between rs823128 polymorphism and the risk of Parkinson\u2019s disease: a meta-analysis. Neurosci Lett 665:110\u2013116","journal-title":"Neurosci Lett"},{"key":"3058_CR17","first-page":"129","volume":"43","author":"D Calne","year":"2001","unstructured":"Calne D (2001) Parkinson\u00b4s disease: a syndrome not a disease. BC Med J 43:129\u20131321","journal-title":"BC Med J"},{"key":"3058_CR18","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1002\/mds.22297","volume":"16","author":"A Camuzat","year":"2008","unstructured":"Camuzat A, Romana M, D\u00fcrr A, Feingold J, Brice A, Ruberg M, Lannuzel A (2008) The PSP-associated MAPT H1 subhaplotype in guadeloupean atypical Parkinsonism. Mov Disord 16:2384\u20132391","journal-title":"Mov Disord"},{"key":"3058_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(98)10166-6","volume":"354","author":"D Caparros-Lefebvre","year":"1999","unstructured":"Caparros-Lefebvre D, Elbaz A (1999) Possible relation of atypical Parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Lancet 354:281\u2013286","journal-title":"Lancet"},{"key":"3058_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/brain\/awf086","volume":"125","author":"D Caparros-Lefebvre","year":"2002","unstructured":"Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C (2002) Guadeloupean Parkinsonism: a cluster of progressive supranuclear palsy \u2013 like tauopathy. Brain 125:801\u2013811","journal-title":"Brain"},{"key":"3058_CR21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/mds.21024","volume":"21","author":"D Caparros-Lefebvre","year":"2006","unstructured":"Caparros-Lefebvre D, Steele J, Kotake Y, Ohta S (2006) Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins. Mov Disord 21:1769\u20131770","journal-title":"Mov Disord"},{"key":"3058_CR22","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1212\/WNL.0000000000001997","volume":"85","author":"D Caparros-Lefebvre","year":"2015","unstructured":"Caparros-Lefebvre D, Golbe LI, Deramecourt V, Maurage CA, Huin V, Bu\u00e9e-Scherrer V, Obriot H, Sablonni\u00e8re B, Caparros F, Bu\u00e9e L, Lees AJ (2015) A geographical cluster of progressive supranuclear palsy in Northern France. Neurology 85:1293\u20131300","journal-title":"Neurology"},{"key":"3058_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/WCO.0000000000001167","volume":"36","author":"A Cherian","year":"2023","unstructured":"Cherian A, Divya KP, Vijayaraghavan A (2023) Parkinson\u00b4s disease\u2014genetic cause. Curr Opin Neurol 36:292\u2013301","journal-title":"Curr Opin Neurol"},{"key":"3058_CR24","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.3390\/ijms242317027","volume":"24","author":"CJ Choong","year":"2023","unstructured":"Choong CJ, Mochizuki H (2023) Involvement of mitochondria in Parkinson\u00b4s disease. Int J Mol Sci 24:17027","journal-title":"Int J Mol Sci"},{"key":"3058_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136288","volume":"765","author":"H Choudry","year":"2021","unstructured":"Choudry H, Aggarwal M, Pan PY (2021) Mini-review: Synaptojanin 1 and its implications in membrane trafficking. Neurosci Lett 765:136288","journal-title":"Neurosci Lett"},{"key":"3058_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05269-1","volume":"81","author":"L Clausen","year":"2024","unstructured":"Clausen L, Okarmus J, Voutsinos V, Meyer M, Lindoff - Larsen K, Hartmann - Petersen R (2024) PRKN-linked familial Parkinson\u00b4s disease: cellular and molecular mechanisms of disease-linked variants. Cell Mol Life Sci 81:233","journal-title":"Cell Mol Life Sci"},{"key":"3058_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40246-024-00704-7","volume":"18","author":"R Coco\u0219","year":"2024","unstructured":"Coco\u0219 R, Popescu BO (2024) Scrutinizing neurodegenerative disease: decoding the complex genetic architectures through a multi-omics lens. Hum Genom 18:141","journal-title":"Hum Genom"},{"key":"3058_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00702-025-02902-6","volume":"132","author":"SEV Cook","year":"2025","unstructured":"Cook SEV, Men\u0161\u00edkov\u00e1 K, Kon\u00ed\u010dkov\u00e1 D, \u0160lanhofov\u00e1 H, Kl\u00ed\u010dov\u00e1 K, Ra\u0161ka M, Zapletalov\u00e1 J, Friedeck\u00fd D, Ka\u0148ovsk\u00fd P (2025) Comparison of inflammatory biomarker levels in neurodegenerative proteinopathies: a case-control study. J Neural Transm 132:811\u2013826","journal-title":"J Neural Transm"},{"key":"3058_CR29","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1212\/WNL.58.6.956","volume":"58","author":"PA Cox","year":"2002","unstructured":"Cox PA, Sacks OW (2002) Cycad neurotoxins, consumption of flying foxes and ALS-PDC disease in Guam. Neurology 58:976\u2013979","journal-title":"Neurology"},{"key":"3058_CR30","doi-asserted-by":"publisher","first-page":"1252400","DOI":"10.3389\/fneur.2023.1252400","volume":"14","author":"KM Croucher","year":"2024","unstructured":"Croucher KM, Fleming SM (2024) ATP13A2 (PARK9) and basal gnaglia function. Front Neurol 14:1252400","journal-title":"Front Neurol"},{"key":"3058_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1039\/C9EM00578A","volume":"22","author":"BR De Miranda","year":"2020","unstructured":"De Miranda BR, Greenamyre JT (2020) Trichlorethylene, a ubiquitious environmental contaminant in the risk of Parkinson\u00b4s disease. Environ Sci Process Impacts 22:543\u2013554","journal-title":"Environ Sci Process Impacts"},{"key":"3058_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ De Boer","year":"2021","unstructured":"De Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T, Silsby M, Menon P, van den Bos M, Halliday GM, van den Berg LH, Van Den Bosch L, van Damme P, Kiernan MC, van Es MA, Vucic S (2021) TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry 92:86\u201395","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3058_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/09727531221089396","volume":"29","author":"M Debnath","year":"2022","unstructured":"Debnath M, Dey S, Sreenivas N, Pal PK, Yadav R (2022) Genetic and epigenetic constructs of progressive supranuclear palsy. Ann Neurosci 29:177\u2013188","journal-title":"Ann Neurosci"},{"key":"3058_CR34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.neurol.2024.03.003","volume":"180","author":"N D\u00e9glon","year":"2024","unstructured":"D\u00e9glon N (2024) Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3. Rev Neurol (Paris) 180:378\u2013382","journal-title":"Rev Neurol (Paris)"},{"key":"3058_CR35","doi-asserted-by":"publisher","first-page":"1351555","DOI":"10.3389\/fsysb.2024.1351555","volume":"4","author":"C Denaro","year":"2024","unstructured":"Denaro C, Stephenson D, M\u00fcller MLTM, Piccoli B, Azer K (2024) Advancing precision medicine therapeutics for Parkinson\u00b4s utilizing a shared quantitative systems pharmacology model and framework. Front Syst Biol 4:1351555","journal-title":"Front Syst Biol"},{"key":"3058_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jamaneurol.2013.572","volume":"70","author":"H Deng","year":"2013","unstructured":"Deng H, Liang H, Jankovic J (2013) F-box only protein gene in parkinsonian\u2014pyramidal disease. JAMA Neurol 70:20\u201324","journal-title":"JAMA Neurol"},{"key":"3058_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002141","volume":"7","author":"CB Do","year":"2011","unstructured":"Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N (2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson\u2019s disease. PLoS Genet 7:e1002141","journal-title":"PLoS Genet"},{"key":"3058_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.conb.2007.04.010","volume":"17","author":"MW Dodson","year":"2007","unstructured":"Dodson MW, Guo M (2007) Pink 1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson\u00b4s disease. Curr Opin Neurobiol 17:331\u2013337","journal-title":"Curr Opin Neurobiol"},{"key":"3058_CR39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jamaneurol.2023.1174","volume":"80","author":"ER Dorsey","year":"2023","unstructured":"Dorsey ER, Greenamyre JT, Willis AW (2023) The water, the air the Marines\u2014Camp Lejeune, trichlorethylene and Parkinson\u00b4s disease. JAMA Neurol 80:663\u2013665","journal-title":"JAMA Neurol"},{"key":"3058_CR40","doi-asserted-by":"crossref","unstructured":"Drouet V, Lesage S (2014) Synaptojanin 1 mutation in Parkinson\u00b4s disease brings further insight into the neuropathological mechanisms. Biomed Res Int. article no 289728","DOI":"10.1155\/2014\/289728"},{"key":"3058_CR41","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/hmg\/ddr026","volume":"20","author":"A Dumitriu","year":"2011","unstructured":"Dumitriu A, Pacheco CD, Wilk JB, Strathearn KE, Latourelle JC, Goldwurm S, Pezzoli G, Rochet JC, Lindquist S, Myers RH (2011) Cyclin-G-associated kinase modifies \u03b1-synuclein expression levels and toxicity in Parkinson\u2019s disease: results from the GenePD Study. Hum Mol Genet 20:1478\u20131487","journal-title":"Hum Mol Genet"},{"key":"3058_CR171","doi-asserted-by":"crossref","unstructured":"Durcan TM, Fon EA. Ataxin 3 and its e3 partners: implications for machado-josephs disease. Front Neurol 2013; 4: 46","DOI":"10.3389\/fneur.2013.00046"},{"key":"3058_CR42","doi-asserted-by":"publisher","first-page":"1222.e1","DOI":"10.1016\/j.neurobiolaging.2014.09.005","volume":"36","author":"DA Dyment","year":"2015","unstructured":"Dyment DA, Smith AC, Humphreys P, Schwartzentruber J, Beaulieu CL, FORGE Canada Consortium, Bulman DE, Majewski J, Woulfe J, Michaud J, Boycott KM (2015) Homozygoues nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology. Neurobiol Aging 36:1222.e1-1222.e5","journal-title":"Neurobiol Aging"},{"key":"3058_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/brain\/awae002","volume":"147","author":"AJ Espay","year":"2024","unstructured":"Espay AJ, Lees AJ (2024a) Are we entering the \u201cTau-lemaic\u201d era of Parkinson\u2019s disease? Brain 147:330\u2013332","journal-title":"Brain"},{"key":"3058_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106077","volume":"122","author":"AJ Espay","year":"2024","unstructured":"Espay AJ, Lees AJ (2024b) Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson\u2019s disease. Parkinsonism Relat Disord 122:106077","journal-title":"Parkinsonism Relat Disord"},{"key":"3058_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107874","volume":"136","author":"AJ Espay","year":"2025","unstructured":"Espay AJ, Lees AJ, Cardoso F, Frucht SJ, Erskine D, Sturchio A, Imarisio A, Hoffmann C, Montemagno KT, Naudi-Fabra S, Milovanovic D, Halliday GM, Manfredsson FP (2025) Alpha-synuclein in Parkinson\u2019s disease: embracing debate, exercising skepticism. Parkinsonism Relat Disord 136:107874","journal-title":"Parkinsonism Relat Disord"},{"key":"3058_CR46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41419-018-0410-7","volume":"9","author":"D Fasano","year":"2018","unstructured":"Fasano D, Parisi S, Pierantoni GM, De Rosa A, Picillo M, Amodio G, Pellecchia MT, Barone P, Moltedo O, Bonifati V, De Michele G, Nitsch L, Remondelli P, Criscuolo C, Paladino S (2018) Alteration of endosomal trafficking is associated with early-onset Parkinsonism caused by SYNJ1 mutations. Cell Death Dis 9:385","journal-title":"Cell Death Dis"},{"key":"3058_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/genes16040454","volume":"16","author":"V Flores-Ocampo","year":"2025","unstructured":"Flores-Ocampo V, Lim AW, Ogonowski NS, Garc\u00eda-Mar\u00edn LM, Ong JS, Yeow D, Gonzaga-Jauregui C, Kumar KR, Renter\u00eda ME (2025) Population-specific differences in pathogenic variants of genes associated with monogenic Parkinson\u2019s disease. Genes 16:454","journal-title":"Genes"},{"key":"3058_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2019.04.043","volume":"706","author":"J Follett","year":"2019","unstructured":"Follett J, Fox JD, Gustavsson EK, Kadgien C, Munsie LN, Cao LP, Tatarnikov I, Milnerwood AJ, Farrer M (2019) DNAJ13 p.Asn855Ser implicated in familial Parkinsonism, alters membrane dynamics of sorting nexin 1. Neurosci Lett 706:114\u2013122","journal-title":"Neurosci Lett"},{"key":"3058_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1017\/cjn.2022.34","volume":"50","author":"SL Forrest","year":"2023","unstructured":"Forrest SL, Kovacs GG (2023) Current concepts of mixed pathologies in neurodegenerative diseases. Can J Neurol Sci 50:329\u2013345","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"3058_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.pathol.2024.10.006","volume":"57","author":"SL Forrest","year":"2025","unstructured":"Forrest SL, Kovacs GG (2025) Currents concepts and molecular pathology of neurodegenerative diseases. Pathology 57(2):178\u2013190","journal-title":"Pathology"},{"key":"3058_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"68","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N (2023) Molecular genetics of Parkinson\u00b4s disease: contributions and global trends. J Hum Genet 68:125\u2013130","journal-title":"J Hum Genet"},{"key":"3058_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1212\/WNL.32.2.107","volume":"32","author":"DC Gajdusek","year":"1982","unstructured":"Gajdusek DC, Salazar AM (1982) Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology 32:107\u2013126","journal-title":"Neurology"},{"key":"3058_CR173","doi-asserted-by":"crossref","unstructured":"Galea E, Graeber M. Neuroinflammation: the abused concept. ASN Neuro 2023; 15: 1 - 11","DOI":"10.1177\/17590914231197523"},{"key":"3058_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-021-00455-2","volume":"16","author":"A Gialluisi","year":"2021","unstructured":"Gialluisi A, Reccia MG, Modugno N, Nutile T, Lombardi A, Di Giovannantonio G, Pietracupa S, Ruggiero D, Scala S, Gambardella S, Iacoviello L, Gianfrancesco F, Acampora D, D\u2019Esposito M, Simeone A, Ciullo M, Esposito T, International Parkinson\u2019s Disease Genomics Consortium (IPDGC) (2021) Identification of sixteen novel candidate genes for late onset Parkinson\u2019s disease. Mol Neurodegener 16:35","journal-title":"Mol Neurodegener"},{"key":"3058_CR54","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WRG Gibb","year":"1988","unstructured":"Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u00b4s disease. J Neurol Neurosurg Psychiatry 51:745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3058_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cm.21812","volume":"81","author":"M Goedert","year":"2023","unstructured":"Goedert M, Crowther RA, Scheres SHW, Spillantini MG (2023) Tau and neurodegeneration. Cytoskeleton 81:95\u2013102","journal-title":"Cytoskeleton"},{"key":"3058_CR56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamaneurol.2023.1168","volume":"80","author":"SM Goldman","year":"2023","unstructured":"Goldman SM, Weaver FM, Stroupe KT, Cao L, Gonzalez B, Colletta K, Brown EG, Tanner CM (2023) Risk of Parkinson\u00b4s disease among service members at Marine Corps Base Camp Lejeune. JAMA Neurol 80:673\u2013681","journal-title":"JAMA Neurol"},{"key":"3058_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147749","volume":"888","author":"O Gupta","year":"2023","unstructured":"Gupta O, Kumar R (2023) GTP cyclohydrolase 1 (GCH1): role in neurodegenerative diseases. Gene 888:147749","journal-title":"Gene"},{"key":"3058_CR165","doi-asserted-by":"crossref","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N. Molecular genetics of Parkinson\u00b4s disease: contrubutions and global trends. J Hum Gen 2023; 68: 125 - 130","DOI":"10.1038\/s10038-022-01058-5"},{"key":"3058_CR163","doi-asserted-by":"crossref","unstructured":"Breydo L, Wu JW, Uversky VN. \u03b1-synuclein misfolding in Parkinson\u00b4s disease. Bioch Biophys Acta 2012; 1822: 261 - 285","DOI":"10.1016\/j.bbadis.2011.10.002"},{"key":"3058_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.30080","volume":"40","author":"EK Gustavsson","year":"2025","unstructured":"Gustavsson EK (2025) Confirmation of RAB32 Ser71Arg involvement in Parkinson\u2019s disease. Mov Disord 40:5\u20136","journal-title":"Mov Disord"},{"key":"3058_CR59","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1474-4422(24)00121-2","volume":"23","author":"EK Gustavsson","year":"2024","unstructured":"Gustavsson EK, Follett J, Trinh J, Barodia SK, Real R, Liu Z, Grant-Peters M, Fox JD, Appel-Cresswell S, Stoessl AJ, Rajput A, Rajput AH, Auer R, Tilney R, Sturm M, Haack TB, Lesage S, Tesson C, Brice A, Vilari\u00f1o-G\u00fcell C, Ryten M, Goldberg MS, West AB, Hu MT, Morris HR, Sharma M, Gan-Or Z, Samanci B, Lis P, Peri\u00f1an MT, Amouri R, Ben Sassi S, Hentati F, Global Parkinson\u2019s Genetics Program (GP2), Tonelli F, Alessi DR, Farrer MJ (2024) RAB32 Ser71Arg in autosomal dominant Parkinson\u2019s disease: linkage, association, and functional analyses. Lancet Neurol 23:603\u2013614","journal-title":"Lancet Neurol"},{"key":"3058_CR60","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00702-024-02863-2","volume":"131","author":"N Hattori","year":"2024","unstructured":"Hattori N, Sato S (2024) Mitochondrial dysfunction in Parkinson\u00b4s disease. J Neural Transm 131:1415\u20131428","journal-title":"J Neural Transm"},{"key":"3058_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"D Hauser","year":"2013","unstructured":"Hauser D, Hastings T (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u00b4s disease and monogenic Parkinsonism. Neurobiol Dis 51:35\u201342","journal-title":"Neurobiol Dis"},{"key":"3058_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neulet.2017.08.022","volume":"657","author":"T He","year":"2017","unstructured":"He T, Wang J, Wang X, Deng W (2017) Association between PARK16 and Parkinson\u00b4s disease: a meta-analysis. Neurosci Lett 657:179\u2013188","journal-title":"Neurosci Lett"},{"key":"3058_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ, Lang AE (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204","journal-title":"Lancet Neurol"},{"key":"3058_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P (2024) Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat Disord 122:106101","journal-title":"Parkinsonism Relat Disord"},{"key":"3058_CR65","doi-asserted-by":"publisher","first-page":"261","DOI":"10.14802\/jmd.23023","volume":"16","author":"YE Huh","year":"2023","unstructured":"Huh YE, Usnich T, Scherzer CR, Klein C, Chung SJ (2023) GBA1 variants and Parkinson\u2019s disease: paving the way for targeted therapy. J Mov Disord 16:261\u2013278","journal-title":"J Mov Disord"},{"key":"3058_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.996061","volume":"10","author":"A Ikeda","year":"2022","unstructured":"Ikeda A, Imai Y, Hattori N (2022) Neurodegeneration\u2014associated mitochondrial proteins, CHCHD2 and CHCHD10: what distinguishes the two? Front Cell Dev Biol 10:996061","journal-title":"Front Cell Dev Biol"},{"key":"3058_CR67","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/ijms20040908","volume":"20","author":"Y Imai","year":"2019","unstructured":"Imai Y, Meng H, Shiba-Fukushima K, Hattori N (2019) Twin CHCH proteins, CHCHD2 and CHCHD10: key molecules of Parkinson\u00b4s disease, amytrophic lateral sclerosis and frontotemporal dementia. Int J Mol Sci 20:908","journal-title":"Int J Mol Sci"},{"key":"3058_CR68","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/jnnp-2020-323646","volume":"91","author":"BM Jacobs","year":"2020","unstructured":"Jacobs BM, Belete D, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls MA, Singleton A, Hardy J, Giovannoni G, Lees AJ, Schrag AE, Noyce AJ (2020) Parkinson\u2019s disease determinants, prediction and gene-environment interactions in the UK Biobank. J Neurol Neurosurg Psychiatry 91:1046\u20131054","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3058_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106038","volume":"123","author":"JR Jacobson","year":"2024","unstructured":"Jacobson JR, Piat C, Aksamit AJ, Patane G (2024) Novel RAB39B loss-of-function mutation in patient with typical early-onset Parkinson\u00b4s disease. Parkinsonism Relat Disord 123:106038","journal-title":"Parkinsonism Relat Disord"},{"key":"3058_CR70","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00702-021-02392-2","volume":"129","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA (2022) Pallidal degenerations and related disorders: an update. J Neural Transm 129:521\u2013543","journal-title":"J Neural Transm"},{"key":"3058_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.988265","volume":"16","author":"T Jiang","year":"2022","unstructured":"Jiang T, Wang Y, Wang X, Xu J (2022) CHCHD2 and CHCHD10: future therapeutic targets in cognitive disorder and motor neuron disorder. Front Neurosci 16:988265","journal-title":"Front Neurosci"},{"key":"3058_CR72","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u00b4s disease. Lancet 386:896\u2013612","journal-title":"Lancet"},{"key":"3058_CR73","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41582-024-01023-0","volume":"20","author":"LV Kalia","year":"2024","unstructured":"Kalia LV, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca DG, Fon EA, Fox S, Gan-Or Z, Gommerman JL, Kang UJ, Klawiter EC, Koch M, Kolind S, Lang AE, Lee KK, Lincoln MR, MacDonald PA, McKeown MJ, Mestre TA, Miron VE, Ontaneda D, Rousseaux MWC, Schlossmacher MG, Schneider R, Stoessl AJ, Oh J (2024) Disease-modifying therapies for Parkinson\u00b4s disease: lessons from multiple sclerosis. Nat Rev Neurol 20:724\u2013737","journal-title":"Nat Rev Neurol"},{"key":"3058_CR74","first-page":"247","volume":"2","author":"TS Kedari","year":"2014","unstructured":"Kedari TS, Khan AA (2014) Guyabano (Annona muricata): a review of its traditional uses, phytochemistry and pharmacology. Am J Res Comm 2:247\u2013268","journal-title":"Am J Res Comm"},{"key":"3058_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.562241","volume":"8","author":"M Kiechle","year":"2020","unstructured":"Kiechle M, Grozdanov V, Danzer KM (2020) The role of lipids in the initiation of \u03b1-synuclein misfolding. Front Cell Dev Biol 8:562241","journal-title":"Front Cell Dev Biol"},{"key":"3058_CR76","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.03.25328628","author":"T Kleinz","year":"2025","unstructured":"Kleinz T, Cavallieri F, Borsche M, Toschi G, Valzania F, Fioravanti V, Valente EM, Mitrotti P, Avenali M, Zittel S, Born R, Matarazzo M, Di Fonzo A, Monfrini E, Radefeldt M, Santinelli L, Griebner N, Shambetova C, Brand M, Gabbert C, Blauwendraat C, Trinh J, Beetz C, Bauer P, Br\u00fcggemann N, Global Parkinson\u2019s Genetics Program (GP2), Klein C (2025) RAB32-linked Parkinson\u2019s disease: deep phenotyping, MDSGene literature review, and application of SynNeurGe criteria. medRxiv. https:\/\/doi.org\/10.1101\/2025.06.03.25328628","journal-title":"medRxiv"},{"key":"3058_CR77","unstructured":"Kmet LM, Lee RC, Cook LS (2004) Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research. 13: 31"},{"key":"3058_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross A, Dickson DW (2021) Neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegener 16:83","journal-title":"Mol Neurodegener"},{"key":"3058_CR79","first-page":"1978","volume":"11","author":"C Kopanos","year":"2018","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, Massouras A (2018) VarSome: the human genomic variant search engine. Bioinformatics 11:1978\u20131980","journal-title":"Bioinformatics"},{"key":"3058_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/genes15121605","volume":"15","author":"C Koros","year":"2024","unstructured":"Koros C, Bougea A, Alefanti I, Simitsi AM, Papagiannakis N, Pachi I, Sfikas E, Antonelou R, Stefanis LA (2024) A global perspective of GBA1-related Parkinson\u00b4s disease: a narrative review. Genes 15:1605","journal-title":"Genes"},{"key":"3058_CR81","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/mds.28605","volume":"36","author":"DJ Koss","year":"2021","unstructured":"Koss DJ, Campesan S, Giorgini F, Outeiro TF (2021) Dysfunction of RAB39B-mediated vesicular trafficking in Lewy body diseases. Mov Disord 36:1744\u20131758","journal-title":"Mov Disord"},{"key":"3058_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12792","volume":"48","author":"GG Kovacs","year":"2022","unstructured":"Kovacs GG, Ghetti B, Goedert M (2022) Classification of diseases with accumulation of tau protein. Neuropathol Appl Neurobiol 48:e12792","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3058_CR83","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/brain\/awl347","volume":"130","author":"A Lannuzel","year":"2007","unstructured":"Lannuzel A, H\u00f6glinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, Poullain P, Oertel WH, Hirsch EC, Dubois B, Ruberg M (2007) Atypical Parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain 130:816\u2013827","journal-title":"Brain"},{"key":"3058_CR84","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/mds.22300","volume":"23","author":"A Lannuzel","year":"2008","unstructured":"Lannuzel A, Ruberg M, Michel PP (2008) Atypical Parkinsonism in the carribean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin. Mov Disord 23:2122\u20132128","journal-title":"Mov Disord"},{"key":"3058_CR85","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jns.2018.02.019","volume":"388","author":"A Lannuzel","year":"2018","unstructured":"Lannuzel A, Edragas R, Lackmy A, Tressi\u00e8res B, Pelonde V, Kaptu\u00e9 MEN, M\u00e9charles S, Demas A, Fran\u00e7ois B, McGovern E, Vidailhet M, Gaymard B, Roze E (2018) Further evidence for a distinctive atypical degenerative Parkinsonism in the Carribean: a new cluster in the French West Indian Island of Martinique. J Neurol Sci 388:214\u2013219","journal-title":"J Neurol Sci"},{"key":"3058_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.777942","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Zhang C, Ji Y (2021) Association of GAK rs1564282 with susceptibility to Parkinson\u00b4s disease in Chinese populations. Front Genet 12:7777942","journal-title":"Front Genet"},{"key":"3058_CR87","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3233\/JPD-230376","volume":"14","author":"SY Lim","year":"2024","unstructured":"Lim SY, Klein C (2024) Parkinson\u00b4s disease is predominantly a genetic disease. J Parkinsons Dis 14:467\u2013482","journal-title":"J Parkinsons Dis"},{"key":"3058_CR88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12974-023-02776-z","volume":"20","author":"F Lind-Holm Mogensen","year":"2023","unstructured":"Lind-Holm Mogensen F, Scafidi A, Michelucci A (2023) PARK7\/DJ-1 in microglia: implications in Parkinson\u00b4s disease and relevance as a therapeutic target. J Neuroinflammation 20:95","journal-title":"J Neuroinflammation"},{"key":"3058_CR89","doi-asserted-by":"publisher","first-page":"140e5","DOI":"10.1016\/j.neurobiolaging.2019.11.001","volume":"87","author":"TW Liu","year":"2020","unstructured":"Liu TW, Wu YR, Chen Y, Fung HC (2020) Association of RIT2 and RAB7L1 with Parkinson\u00b4s disease: a case-control study in a Taiwanese colhort and meta-analysis in Asian populations. Neurobiol Aging 87:140e5-140.e11","journal-title":"Neurobiol Aging"},{"key":"3058_CR91","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/00207454.2018.1526796","volume":"129","author":"F Lou","year":"2019","unstructured":"Lou F, Li M, Liu N, Ren Y et al (2019) The polymorphis of SREBF1 gene rs11868035 G\/A is associated with susceptibility to Parkinson\u00b4s disease in a Chinese population. Int J Neurosci 129:660\u2013665","journal-title":"Int J Neurosci"},{"key":"3058_CR92","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1093\/brain\/awad214","volume":"146","author":"MB Makarious","year":"2023","unstructured":"Makarious MB, Lake J, Pitz V, Ye FA, Guidubaldi JL, Solsberg CW, Bandres- Ciga S, Leonard HL, Kim JJ, Billingsley KJ, Grenn FP, Jerez PA, Alvarado CX, Iwaki H, Ta M, Vitale D, Hernandez D, Torkamani A, Ryten M, Hardy J, Scholz SW, Traynor BJ, Dalgard CL, Ehrlich DJ, Tanaka T, Ferrucci L, Beach TG, Serrano GE, Real R, Morris HR, Ding J, Gibbs JR, Singleton AB, Nalls MA, Bhangale T, Blauwendraat C, UK Brain Expression Consortium (UKBEC) (2023) Large-scale rare variant burden testing in Parkinson\u2019s disease. Brain 146:4622\u20134632","journal-title":"Brain"},{"key":"3058_CR93","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/awae269","volume":"148","author":"M Malpetti","year":"2025","unstructured":"Malpetti M, Swann P, Tsvetanov KA, Chouliaras L, Strauss A, Chikaura T, Murley AG, Ashton NJ, Barker P, Jones PS, Fryer TD, Hong YT, Cope TE, Savulich G, Street D, Bevan-Jones WR, Rittman T, Blennow K, Zetterberg H, Aigbirhio FI, O\u2019Brien JT, Rowe JB (2025) Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration. Brain 148:493\u2013505","journal-title":"Brain"},{"key":"3058_CR94","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.21273\/HORTSCI.40.6.1598","volume":"40","author":"TE Marler","year":"2005","unstructured":"Marler TE, Lee V, Shaw C (2005) Cycad toxins and neurological disorders on Guam: defining theoretical and experimental standars for correlating human disease with environmental toxins. HortScience 40:1598\u20131606","journal-title":"HortScience"},{"key":"3058_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0045-4","volume":"10","author":"IF Mata","year":"2015","unstructured":"Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Schprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, Litvan I, Leverenz JB, Yearout D, Inca-Martinez M, Martinez E, Thompson TR, Cholerton BA, Hu SC, Edwards KL, Kim KS, Zabetian CP (2015) The RAB39B p.G192R mutation causes X-linked dominant Parkinson\u2019s disease. Mol Neurodegener 10:50","journal-title":"Mol Neurodegener"},{"key":"3058_CR96","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13284","volume":"34","author":"S Mazzetti","year":"2024","unstructured":"Mazzetti S, Contaldi E, Baselini MJ, Novello C (2024) Comparing GBA1-Parkinson\u00b4sdisease and idiopathic Parkinson\u00b4s disease: \u03b1-synuclein oligomers and synaptic density as biomarkers in the skin biopsy. Brain Pathol 34:e13284","journal-title":"Brain Pathol"},{"key":"3058_CR97","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1093\/brain\/awu179","volume":"137","author":"NE Mencacci","year":"2014","unstructured":"Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Bras J, Hersheson J, Stamelou M, Pittman AM, Noyce AJ, Mok KY, Opladen T, Kunstmann E, Hodecker S, M\u00fcnchau A, Volkmann J, Samnick S, Sidle K, Nanji T, Sweeney MG, Houlden H, Batla A, Zecchinelli AL, Pezzoli G, Marotta G, Lees A, Alegria P, Krack P, Cormier-Dequaire F, Lesage S, Brice A, Heutink P, Gasser T, Lubbe SJ, Morris HR, Taba P, Koks S, Majounie E, Raphael Gibbs J, Singleton A, Hardy J, Klebe S, Bhatia KP, Wood NW (2014) Parkinson\u00b4s disease in GTP cyclohydrolase 1 mutation carriers. Brain 137:2480\u20132492","journal-title":"Brain"},{"key":"3058_CR98","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-018-1923-y","volume":"137","author":"K Men\u0161\u00edkov\u00e1","year":"2019","unstructured":"Men\u0161\u00edkov\u00e1 K, Tu\u010dkov\u00e1 L, Kola\u0159\u00edkov\u00e1 K, Barton\u00edkov\u00e1 T, Vodi\u010dka R, Ehrmann J, Vrt\u011bl R, Proch\u00e1zka M, Ka\u0148ovsk\u00fd P, Kovacs GG (2019) Atypical Parkinsonism of progressive supranuclear palsy-Parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology. Acta Neuropathol 137:171\u2013173","journal-title":"Acta Neuropathol"},{"key":"3058_CR99","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41582-023-00866-3","volume":"19","author":"K Men\u0161\u00edkov\u00e1","year":"2023","unstructured":"Men\u0161\u00edkov\u00e1 K, Steele JC, Rosales R, Colosimo C, Spencer P, Lannuzel A, Ugawa Y, Sasaki R, Gim\u00e9nez-Rold\u00e1n S, Matej R, Tuckova L, Hrabos D, Kolarikova K, Vodicka R, Vrtel R, Strnad M, Hlustik P, Otruba P, Prochazka M, Bares M, Boluda S, Buee L, Ransmayr G, Ka\u0148ovsk\u00fd P (2023) Endemic Parkinsonism: clusters, biology and clinical features. Nat Rev Neurol 19:599\u2013616","journal-title":"Nat Rev Neurol"},{"key":"3058_CR101","doi-asserted-by":"publisher","first-page":"1575022","DOI":"10.3389\/fncel.2025.1575022","volume":"19","author":"L M\u00fcller","year":"2025","unstructured":"M\u00fcller L, Di Benedetto S (2025) Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation. Front Cell Neurosci 19:1575022","journal-title":"Front Cell Neurosci"},{"key":"3058_CR102","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00702-023-02673-y","volume":"131","author":"T Nagatsu","year":"2024","unstructured":"Nagatsu T (2024) Catecholamines and Parkinson\u00b4s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydroLASE i (gch1) to cytokines, neuromelanin and gene therapy: a historical overview. J Neural Transm 131:617\u2013630","journal-title":"J Neural Transm"},{"key":"3058_CR103","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF02529141","volume":"21","author":"T Nagatsu","year":"1996","unstructured":"Nagatsu T, Ichinose H (1996) GTP cyclohydrolase I gene, tetrahydrobiopterin and tyrosine hydrolase gene: their relations to dystonia and parkinsonis. Neurochem Res 21:245\u2013250","journal-title":"Neurochem Res"},{"key":"3058_CR167","doi-asserted-by":"crossref","unstructured":"Navarro E, Esteras N. A new mutation in the Parkinson\u00b4s-related FBXO7 gene impairs mitochondrial and proteasomal function. FEBS J 2024; 291: 2562 - 2564","DOI":"10.1111\/febs.17155"},{"key":"3058_CR104","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.130131","volume":"3","author":"DE Nelson","year":"2013","unstructured":"Nelson DE, Randle SJ, Laman H (2013) Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins. Open Biol 3:130131","journal-title":"Open Biol"},{"key":"3058_CR105","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.4103\/NRR.NRR-D-23-01624","volume":"19","author":"XY Ng","year":"2024","unstructured":"Ng XY, Cao M (2024) Dysfunction of synaptic endocytic trafficking in Parkinson\u00b4s disease. Neural Regen Res 19:2649\u20132660","journal-title":"Neural Regen Res"},{"key":"3058_CR106","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004353","volume":"4","author":"K Okumiya","year":"2014","unstructured":"Okumiya K, Wada T, Fujisawa M, Ishine M, Garcia Del Saz E, Hirata Y, Kuzuhara S, Kokubo Y, Seguchi H, Sakamoto R, Manuaba I, Watofa P, Rantetampang AL, Matsubayashi K (2014) Amyotrophic lateral sclerosis and Parkinsonism in Papua, Indonesia: 2001\u20132012 survey results. BMJ Open 4:e004353","journal-title":"BMJ Open"},{"key":"3058_CR107","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12883-023-03202-w","volume":"23","author":"S Ouchi","year":"2023","unstructured":"Ouchi S, Ishii K, Kosaki K, Suzuki H, Yamada M, Takenouchi T, Tamaoka A (2023) Parkinsonism in spinocerebellar ataxia with axonal neuropathy caused by adult- onset COA7 variants: a case report. BMC Neurol 23:211","journal-title":"BMC Neurol"},{"key":"3058_CR108","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5607\/en.2014.23.4.324","volume":"23","author":"A Oueslati","year":"2014","unstructured":"Oueslati A, Ximerakis M, Vekrelis K (2014) Protein transmission, seeding and degradation: key steps for \u03b1-synuclein prion-like propagation. Exp Neurobiol 23:324\u2013336","journal-title":"Exp Neurobiol"},{"key":"3058_CR109","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzia JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Choru R, Glanville J, Grimshav JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuiness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whitting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"3058_CR110","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/125273","volume":"2015","author":"H Park","year":"2015","unstructured":"Park H, Kim HJ, Jeon BS (2015a) Parkinsonism in spinocerebellar ataxia. Biomed Res Int 2015:125273","journal-title":"Biomed Res Int"},{"key":"3058_CR111","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/mds.26243","volume":"30","author":"JS Park","year":"2015","unstructured":"Park JS, Blair NF, Sue CM (2015b) The role of Atp13a2 in Parkinson\u00b4s disease: clinical phenotypes and molecular mechanisms. Mov Disord 30:770\u2013778","journal-title":"Mov Disord"},{"key":"3058_CR112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-024-00731-x","volume":"19","author":"C Pedicone","year":"2024","unstructured":"Pedicone C, Weitzman SA, Renton AE, Goate AM (2024) Unraveling the complex role of MAPT \u2013 containing H1 and H2 haplotypes in neurodegenerative diseases. Mol Neurodegener 19:43","journal-title":"Mol Neurodegener"},{"key":"3058_CR168","doi-asserted-by":"crossref","unstructured":"Peng H, Liang X, Long Z, Cehn Z, Shi Y, Xia K, Meng L, Tang B, Qui R, Jiang H. Gene-related cerebellar neurodegeneration in SCA3\/MJD: a case-controlled imaging genetic study. Front Neurol 2019; 10: 1025","DOI":"10.3389\/fneur.2019.01025"},{"key":"3058_CR113","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.26467","volume":"92","author":"MT Peri\u00f1\u00e1n","year":"2022","unstructured":"Peri\u00f1\u00e1n MT, Brolin K, Bandres-Ciga S, Blauwendraat C, Klein C, Gan-Or Z, Singleton A, Gomez-Garre P, Swanberg M, Mir P, Noyce A (2022) Effect modification between genes and environment and Parkinson\u2019s disease risk. Ann Neurol 92:715\u2013724","journal-title":"Ann Neurol"},{"key":"3058_CR114","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/archneur.1975.00490440058009","volume":"32","author":"TL Perry","year":"1975","unstructured":"Perry TL, Bratty PJ, Hansen S, Kennedy J, Urquhart N, Dolman CL (1975) Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol 32:108\u2013113","journal-title":"Arch Neurol"},{"key":"3058_CR115","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"3058_CR116","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"3058_CR117","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s10020-021-00281-8","volume":"27","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Br\u00fcggemann N (2021) Genotype-driven therapeutic developments in Parkinson\u2019s disease. Mol Med 27:42","journal-title":"Mol Med"},{"key":"3058_CR118","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1111\/jnc.16184","volume":"168","author":"Z Qui","year":"2024","unstructured":"Qui Z, Deng X, Fu Y, Jiang M, Cui X (2024) Exploring the triad: VPS35, neurogenesis and neurodegenerative diseases. J Neurochem 168:2363\u20132378","journal-title":"J Neurochem"},{"key":"3058_CR119","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/1389203717666160311121433","volume":"18","author":"SJ Randel","year":"2017","unstructured":"RandleSJ, Laman H (2017) Structure and function of FBXO7\/PARK15 in Parkinson\u00b4s disease. Curr Protein Pept Sci 18:715\u2013724","journal-title":"Curr Protein Pept Sci"},{"key":"3058_CR120","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.26852","volume":"95","author":"A Reynoso","year":"2024","unstructured":"Reynoso A, Torricelli R, Jacobs BM, Shi J, Aslibekyan S, Norcliffe-Kaufmann L, Noyce AJ, Heilbron K (2024) Gene-environment interactions for Parkinson\u2019s disease. Ann Neurol 95:677\u2013687","journal-title":"Ann Neurol"},{"issue":"1899","key":"3058_CR121","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2022.0384","volume":"379","author":"J Rowlands","year":"2022","unstructured":"Rowlands J, Moore DJ (2022) VPS35 and retromer dysfunction in Parkinson\u00b4s disease. Philos Trans R Soc Lond B Biol Sci 379(1899):20220384","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3058_CR122","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1017\/cjn.2020.252","volume":"48","author":"G Saranza","year":"2021","unstructured":"Saranza G, Lang AE (2021) Differences in drug pharmacokinetics and motor fluctuation in DYT-GCH1. Can J Neurol Sci 48:734\u2013736","journal-title":"Can J Neurol Sci"},{"key":"3058_CR123","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.expneurol.2011.12.012","volume":"234","author":"A Sauerbeck","year":"2012","unstructured":"Sauerbeck A, Hunter R, Bing G, Sullivan PG (2012) Traumatic brain injury and trichlorethylene interacts and produce functional, histological and mitochondrial deficits. Exp Neurol 234:85\u201394","journal-title":"Exp Neurol"},{"key":"3058_CR169","doi-asserted-by":"crossref","unstructured":"Schols L, Peters S, Szymanski S, Kruger R, Lange S, Hardt C, Riess O, Przuntek H. Extrapyramidal motor signs in degenerative ataxias. Arch Neurol 2000; 57: 1495 - 1500","DOI":"10.1001\/archneur.57.10.1495"},{"key":"3058_CR124","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/BST20221365","volume":"51","author":"MK Shammas","year":"2023","unstructured":"Shammas MK, Huang TH, Naredra DP (2023) CHCHD2 abd CHCHD10 related neurodegeneration: molecular pathogenessis and path to precision therapy. Biochem Soc Trans 51:797\u2013809","journal-title":"Biochem Soc Trans"},{"key":"3058_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00757-4","volume":"10","author":"J Sikora","year":"2024","unstructured":"Sikora J, Dovero S, Kinet R, Arotcarena ML, Bohic S, Bezard E, Fernagut PO, Dehay B (2024) Nigral ATP13A2 depletion induces Parkinson\u00b4s disease-related neurodegeneration in a pilot study in non-human primates. NPJ Parkinsons Dis 10:141","journal-title":"NPJ Parkinsons Dis"},{"key":"3058_CR126","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K (2024) A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23:178\u2013190","journal-title":"Lancet Neurol"},{"key":"3058_CR127","unstructured":"Singh A, Wu L (2020) A case report of spinocerebellar ataxia 13 with Parkinsonism (abstract). Mov Disord 35 (suppl. 1): https:\/\/www.mdsabstracts.org\/abstract\/a-case-report-of-spinocerebellar-ataxia-13-with-Parkinsonism"},{"key":"3058_CR128","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/genes12101529","volume":"12","author":"M Sj\u00f6gren","year":"2021","unstructured":"Sj\u00f6gren M, Huttunen HJ, Svenningsson P, Widner H (2021) Genetically targeted clinical trials in Parkinson\u2019s disease: learning from the successes made in oncology. Genes (Basel) 12:1529","journal-title":"Genes (Basel)"},{"key":"3058_CR129","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/cells13040296","volume":"13","author":"LD Skou","year":"2024","unstructured":"Skou LD, Johansen SK, Okarmus J, Meyer M (2024) Pathogenesis of DJ-1\/PARK7 mediated Parkinson\u00b4s disease. Cells 13:296","journal-title":"Cells"},{"key":"3058_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137102","volume":"25","author":"A Skrahin","year":"2024","unstructured":"Skrahin A, Horowitz M, Istaiti M, Skrahina V, Lukas J, Yahalom G, Cohen ME, Revel-Vilk S, Goker-Alpan O, Becker-Cohen M, Hassin-Baer S, Svenningsson P, Rolfs A, Zimran A (2024) GBA1-associated Parkinson\u00b4sdisease is a distinct entity. Int J Mol Sci 25:7102","journal-title":"Int J Mol Sci"},{"key":"3058_CR131","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.4103\/NRR.NRR-D-24-00284","volume":"20","author":"R Socodato","year":"2025","unstructured":"Socodato R, Relvas JB (2025) Neuroinflammation revisited through the microglial lens. Neural Regen Res 20:1989\u20131990","journal-title":"Neural Regen Res"},{"key":"3058_CR132","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/acn3.51776","volume":"10","author":"YL Sosero","year":"2023","unstructured":"Sosero YL, Gan-Or Z (2023) LRRK2 and Parkinson\u00b4s disease: from genetics to targeted therapy. Ann Clin Transl Neurol 10:850\u2013864","journal-title":"Ann Clin Transl Neurol"},{"key":"3058_CR133","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.ant.2017.07.009","volume":"1","author":"PS Spencer","year":"2017","unstructured":"Spencer PS, Palmer VS (2017) Food plant chemicals linked with neurological and neurodegenerative disease. Adv Neurotoxicol 1:247\u2013267","journal-title":"Adv Neurotoxicol"},{"key":"3058_CR134","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(87)91883-6","volume":"2","author":"PS Spencer","year":"1987","unstructured":"Spencer PS, Palmer VS, Herman A, Asmedi A (1987) Cycad use and motor neurone disease in Irian Jaya. Lancet 2:1273\u20131274","journal-title":"Lancet"},{"key":"3058_CR135","first-page":"37","volume":"46","author":"PS Spencer","year":"1991","unstructured":"Spencer PS, Kisby GE, Ludolph AC (1991) Long-latency neurodegenerative disease in the western Pacific. Geriatrics 46:37\u201342","journal-title":"Geriatrics"},{"key":"3058_CR136","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.20552","volume":"20","author":"PS Spencer","year":"2005","unstructured":"Spencer PS, Palmer VS, Ludolph AC (2005) On the decline and etiology of high-incidence motor system disease in West Papua (Southwest New Guinea). Mov Disord 20:119\u2013126","journal-title":"Mov Disord"},{"key":"3058_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2020.100230","volume":"18","author":"PS Spencer","year":"2020","unstructured":"Spencer PS, Palmer VS, Kihira T, Yoshida S, Reis J, Yabushita M, Yase Y (2020) Kampo medicine and Muro disease (amyotrophic lateral sclerosis and Parkinsonism \u2013 dementia complex). eNeurologicalSci 18:100230","journal-title":"eNeurologicalSci"},{"key":"3058_CR138","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","volume":"17","author":"M Stamelou","year":"2021","unstructured":"Stamelou M, Respondek G, Giagkou N, Whitwell JL, Kovacs GG (2021) Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies. Nat Rev Neurol 17:601\u2013620","journal-title":"Nat Rev Neurol"},{"key":"3058_CR139","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1212\/01.wnl.0000312571.81091.26","volume":"70","author":"JC Steele","year":"2008","unstructured":"Steele JC, McGeer PL (2008) The ALS\/PDC syndrome of Guam and the cycad hypothesis. Neurology 70:1984\u20131990","journal-title":"Neurology"},{"key":"3058_CR140","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1353-8020(02)00043-3","volume":"9","author":"JC Steele","year":"2002","unstructured":"Steele JC, Caparros-Lefebvre D, Lees AJ, Sacks OW (2002) Progressive supranuclear palsy and its relation to pacific foci of the Parkinsonism-dementia complex and guadeloupean Parkinsonism. Park Relat Disord 9:39\u201354","journal-title":"Park Relat Disord"},{"key":"3058_CR141","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00702-014-1179-1","volume":"121","author":"W Struhal","year":"2014","unstructured":"Struhal W, Presslauer S, Spielberger S, Zimprich A, Auff E, Bruecke T, Poewe W, Ransmayr G (2014) VPS35 Parkinson\u00b4s disease phenotype resembles the sporadic disease. J Neural Transm 121:755\u2013759","journal-title":"J Neural Transm"},{"key":"3058_CR142","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.3390\/ijms24087409","volume":"24","author":"MO Sun","year":"2023","unstructured":"Sun MO, Zheng Q (2023) The tale of DJ-1 (PARK7): a Swiss army knife in biomedical and psychological research. Int J Mol Sci 24:7409","journal-title":"Int J Mol Sci"},{"key":"3058_CR143","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neures.2020.01.006","volume":"159","author":"K Tanaka","year":"2020","unstructured":"Tanaka K (2020) The PINK1 \u2013 Parkin axis: an overview. Neurosci Res 159:9\u201315","journal-title":"Neurosci Res"},{"key":"3058_CR144","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41531-023-00544-7","volume":"9","author":"JM Taymans","year":"2023","unstructured":"Taymans JM, Fell M, Greenamyre T, Hirst WD, Mamais A, Padmanabhan S, Peter I, Rideout H, Thaler A (2023) Perspective on the current state of the LRRK2 field. NPJ Parkinsons Dis 9:104","journal-title":"NPJ Parkinsons Dis"},{"key":"3058_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134425","volume":"712","author":"C Tejerra-Parado","year":"2019","unstructured":"Tejerra-Parado C, Jes\u00fas S, Perinan MT, Buiza-Rueda D, Oliva-Ariza G, Adarmes-G\u00f3mez AD, Mac\u00edas-Garc\u00eda D, G\u00f3mez-Carre P, Mir P (2019) A replication study of GWAS-genetic risk variants associated tih Parkinson\u00b4s disease in a Spanish population. Neurosci Lett 712:134425","journal-title":"Neurosci Lett"},{"key":"3058_CR146","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1021\/acsomega.4c09114","volume":"10","author":"R Tenchov","year":"2025","unstructured":"Tenchov R, Sasso JM, Zhou QA (2025) Evolving landscape of Parkinson\u00b4s disease research: challenges and perspectives. ACS Omega 10:1664\u20131892","journal-title":"ACS Omega"},{"key":"3058_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107512","volume":"169","author":"T Tong","year":"2022","unstructured":"Tong T, Duan W, Xu Y, Hong H, Xu J, Fu G, Wang X, Yang L, Deng P, Zhang J, He H, Mao G, Lu Y, Lin X, Yu Z, Pi H, Cheng Y, Xu S, Zhou Z (2022) Paraquat exposure induces Parkinsonism by altering lipid profile and evoking neuroinflammation in the midbrain. Environ Int 169:107512","journal-title":"Environ Int"},{"key":"3058_CR148","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tun\u00e7alp \u00d6, Straus SE (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467\u2013473","journal-title":"Ann Intern Med"},{"key":"3058_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00568-z","volume":"9","author":"M Tsalenchuk","year":"2023","unstructured":"Tsalenchuk M, Gentleman SM, Marzi SJ (2023) Linking environmental risk factors with epigenetic mechanisms in Parkinson\u00b4s disease. NPJ Parkinsons Dis 9:123","journal-title":"NPJ Parkinsons Dis"},{"key":"3058_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.20060","volume":"14","author":"Y Tsuboi","year":"2021","unstructured":"Tsuboi Y, Mishima T, Fujioka S (2021) Perry disease: concept of a new disease and clinical diagnostic criteria. J Mov Disord 14:1\u20139","journal-title":"J Mov Disord"},{"key":"3058_CR151","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/ejn.12872","volume":"41","author":"C Van der Merve","year":"2015","unstructured":"Van der Merve C, Dashti ZJS, Christoffels A, Loos B, Bardien S (2015) Evidence for a common biological pathway linking three Parkinson\u00b4s disease\u2014causing genes: parkin, PINK1 and DJ-1. Eur J Neurosci 41:1113\u20131125","journal-title":"Eur J Neurosci"},{"key":"3058_CR172","doi-asserted-by":"crossref","unstructured":"Weiner WJ. There is no Parkinson\u00b4s disease. Arch Neurol 2008; 65: 705 - 8","DOI":"10.1001\/archneur.65.6.705"},{"key":"3058_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105768","volume":"170","author":"ET Williams","year":"2022","unstructured":"Williams ET, Chen X, Otero PA, Moore DJ (2022) Understanding the contributions of VPS35 and the retromer in neurodegenerative disease. Neurobiol Dis 170:105768","journal-title":"Neurobiol Dis"},{"key":"3058_CR153","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ajhg.2014.10.015","volume":"95","author":"GR Wilson","year":"2014","unstructured":"Wilson GR, Sim JC, McLean C, Giannandrea M, Galea CA, Riseley JR, Stephenson SE, Fitzpatrick E, Haas SA, Pope K, Hogan KJ, Gregg RG, Bromhead CJ, Wargowski DS, Lawrence CH, James PA, Churchyard A, Gao Y, Phelan DG, Gillies G, Salce N, Stanford L, Marsh AP, Mignogna ML, Hayflick SJ, Leventer RJ, Delatycki MB, Mellick GD, Kalscheuer VM, D\u2019Adamo P, Bahlo M, Amor DJ, Lockhart PJ (2014) Mutations in RAB39B cause X-linked intellectual disability and eraly-onset Parkinson disease with \u03b1-synuclein pathology. Am J Hum Genet 95:729\u2013735","journal-title":"Am J Hum Genet"},{"key":"3058_CR154","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.molmed.2024.07.003","volume":"30","author":"Y Xiong","year":"2024","unstructured":"Xiong Y, Yu J (2024) LRRK2 in Parkinson\u00b4s disease: upstream regulation and therapeutic targetting. Trends Mol Med 30:982\u2013989","journal-title":"Trends Mol Med"},{"key":"3058_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076338","volume":"24","author":"V Yahya","year":"2023","unstructured":"Yahya V, Di Fonzo A, Monfrini E (2023) Genetic evidence for endolysosomal dysfunction in Parkinson\u00b4s disease: a critical overview. Int J Mol Sci 24:6338","journal-title":"Int J Mol Sci"},{"key":"3058_CR156","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10565-021-09617-w","volume":"38","author":"SMS Yakhine-Diop","year":"2022","unstructured":"Yakhine-Diop SMS, Rodr\u00edguez-Arribas M, Canales-Cort\u00e9s S, Mart\u00ednez-Chac\u00f3n G, Uribe-Carretero E, Blanco-Ben\u00edtez M, Duque-Gonz\u00e1lez G, Paredes-Barquero M, Alegre-Cort\u00e9s E, Climent V, Aiastui A, de L\u00f3pez Munain A, Bravo-San Pedro JM, Niso-Santano M, Fuentes JM, Gonz\u00e1lez-Polo RA (2022) The parkinsonian LRRK2 R1441G mutation shows macroautophagy\u2014mitophagy dysregulation concomitant with endoplasmic reticuluzm stress. Cell Biol Toxicol 38:889\u2013911","journal-title":"Cell Biol Toxicol"},{"key":"3058_CR157","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/371256","volume":"2014","author":"X Yang","year":"2014","unstructured":"Yang X, Xu Y (2014) Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review. Biomed Res Int 2014:371256","journal-title":"Biomed Res Int"},{"key":"3058_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010389","volume":"26","author":"LX Yi","year":"2025","unstructured":"Yi LX, Tan EK, Zhou ZD (2025) The \u03b1-synuclein seeding amplification assay for Parkinson\u00b4s disease. Int J Mol Sci 26:389","journal-title":"Int J Mol Sci"},{"key":"3058_CR159","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/hmg\/ddy003","volume":"27","author":"S Yoshida","year":"2018","unstructured":"Yoshida S, Hasegawa T, Suzuki M, Sugeno N, Kobayashi J, Ueyama M, Fukuda M, Ido-Fujibayashi A, Sekiguchi K, Ezura M, Kikuchi A, Baba T, Takeda A, Mochizuki H, Nagai Y, Aoki M (2018) Parkinson\u00b4s disease \u2013 linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking. Hum Mol Gen 27:823\u2013836","journal-title":"Hum Mol Gen"},{"key":"3058_CR160","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1007\/s00415-018-8930-8","volume":"265","author":"H Yoshino","year":"2018","unstructured":"Yoshino H, Nishioka K, Li Y, Oji Y, Oyama G, Hatano T, Machida Y, Shimo Y, Hayashida A, Ikeda A, Mogushi K, Shibagaki Y, Hosaka A, Iwanaga H, Fujitake J, Ohi T, Miyazaki D, Sekijima Y, Oki M, Kusaka H, Fujimoto KI, Ugawa Y, Funayama M, Hattori N (2018) GCH1 mutations in dopa-responsive dystonia and Parkinson\u00b4s disease. J Neurol 265:1860\u20131870","journal-title":"J Neurol"},{"key":"3058_CR161","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2017.11.015","volume":"664","author":"X Yuan","year":"2018","unstructured":"Yuan X, Cao B, Wu Y, Chen Y, Wei Q, Ou R, Yang J, Chen X, Zhao B, Song W, Shang H (2018) Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson\u00b4s disease, sporadic amytrophic lateral sclerosis and multiple system atrophy in a Chinese population. Neurosci Lett 664:128\u2013132","journal-title":"Neurosci Lett"},{"key":"3058_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2021.12.003","volume":"356","author":"X Yuan","year":"2021","unstructured":"Yuan X, Tian Y, Liu C, Zhang Z (2021) Environmental factors in Parkinson\u00b4s disease: new insights into molecular mechanisms. Toxicol Lett 356:1\u201310","journal-title":"Toxicol Lett"},{"key":"3058_CR166","doi-asserted-by":"crossref","unstructured":"Zhou ZD, Lee JCT, Tan EK. Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson\u00b4s disease (PD). Mutation Research - Reviews 2018; 778: 72 - 78","DOI":"10.1016\/j.mrrev.2018.10.001"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03058-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03058-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03058-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:02:38Z","timestamp":1785603758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03058-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":170,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3058"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03058-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors reported conflict of interest related to this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}